P
BREAKING: Pfizer files for U.S. authorization of its experimental COVID-19 pill, which cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial https://t.co/vMnnTxm4Lf pic.twitter.com/Cfqp0qZ4q4
— Reuters (@Reuters) November 16, 2021
Source: Twitter
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.